Nantahala Capital Management, LLC Amryt Pharma PLC Transaction History

Nantahala Capital Management, LLC

  • $1.68 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023
SELL
$7.0 - $14.77 $4.32 Million - $9.11 Million
-616,633 Reduced 42.9%
820,825 $12 Million
Q3 2022

Nov 10, 2022
SELL
$6.8 - $8.01 $850,000 - $1 Million
-125,000 Reduced 8.0%
1,437,458 $9.95 Million
Q2 2022

Aug 15, 2022
BUY
$6.85 - $8.87 $3.36 Million - $4.35 Million
490,922 Added 45.81%
1,562,458 $10.9 Million
Q1 2022

May 13, 2022
BUY
$6.3 - $10.86 $6.75 Million - $11.6 Million
1,071,536 New
1,071,536 $8.86 Million

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Nantahala Capital Management, LLC Portfolio

Follow Nantahala Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nantahala Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nantahala Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email